107 related articles for article (PubMed ID: 3162905)
1. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
Bates SA; Elder MG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
[TBL] [Abstract][Full Text] [Related]
2. Enoxacin distribution in human tissues after multiple oral administration.
Malmborg AS; Rannikko S
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
[TBL] [Abstract][Full Text] [Related]
3. Penetration of trovafloxacin into gynecologic tissues.
Martens MG; Maccato M; Van Hook C; Vincent J
Am J Surg; 1998 Dec; 176(6A Suppl):18S-22S. PubMed ID: 9935252
[TBL] [Abstract][Full Text] [Related]
4. Bone penetration of enoxacin in patients with and without osteomyelitis.
Fong IW; Rittenhouse BR; Simbul M; Vandenbroucke AC
Antimicrob Agents Chemother; 1988 Jun; 32(6):834-7. PubMed ID: 3166359
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
[TBL] [Abstract][Full Text] [Related]
7. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
9. Fleroxacin concentrations in myometrium, ovary and fallopian tube.
Portmann R; Hansz C; Stiglmayer R; Weidekamm E
J Antimicrob Chemother; 1989 Apr; 23(4):662-4. PubMed ID: 2501273
[No Abstract] [Full Text] [Related]
10. [Enoxacin concentration in human prostatic tissue].
Yasumoto R; Kobayakawa H; Asakawa M
Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
[TBL] [Abstract][Full Text] [Related]
12. Single and multiple dose pharmacokinetics of ciprofloxacin in gynecological tissues.
Gerstner GJ; Dalhoff A; Weuta H
Infection; 1988; 16 Suppl 1():S24-8. PubMed ID: 3372029
[TBL] [Abstract][Full Text] [Related]
13. Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1988 Feb; 32(2):262-4. PubMed ID: 3163241
[TBL] [Abstract][Full Text] [Related]
14. Enoxacin in the treatment of sexually transmitted diseases.
Siboulet A; Bohbot JM; Catalan F
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():119-24. PubMed ID: 3283097
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract.
Whelton A; Blanco LJ; Carter GG; Craig TJ; Bryant HH; Herbst DV; King TM
Obstet Gynecol; 1980 Jan; 55(1):28-32. PubMed ID: 7352059
[TBL] [Abstract][Full Text] [Related]
16. Oral treatment of systemic Pseudomonas aeruginosa infection with enoxacin.
Hubrechts JM; Vanhoof R; Servais J; Toen R; Sacré J; van Gysel JP
Lancet; 1984 Apr; 1(8381):860. PubMed ID: 6143180
[No Abstract] [Full Text] [Related]
17. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue.
Daschner FD; Petersen EE; Just HM; Hillemanns HG
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():247-9. PubMed ID: 6352627
[TBL] [Abstract][Full Text] [Related]
18. [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
Morel C; Vergnaud M; Malbruny B; Benard Y
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):781-4. PubMed ID: 3309815
[TBL] [Abstract][Full Text] [Related]
19. Thyroid transcription factor-1 expression in normal gynecologic tissues and its potential significance.
Niu HL; Pasha TL; Pawel BR; LiVolsi VA; Zhang PJ
Int J Gynecol Pathol; 2009 Jul; 28(4):301-7. PubMed ID: 19483637
[TBL] [Abstract][Full Text] [Related]
20. Penetration of cefonicid into serum, salpinges, cervix and vaginal tissue.
Goisis M; Grossi F; Soncini R; Gusmitta A
J Chemother; 1991 Feb; 3(1):28-9. PubMed ID: 2019859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
